Drugs / Kang Guan Recipe
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06291883 | Feb → Apr 2023 | COVID-19 | Sheng-Teng Huang | Completed | No outcome recorded |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Kang Guan Recipe | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06291883 ↗ |
| Known as | KGR | “novel herbal medicine formula Kang Guan Recipe (KGR) is a potent inhibitor against SARS-CoV-2 viral infection” NCT06291883 ↗ |
| Action | Inhibit | “KGR can block the interaction of viral Spike and human angiotensin-converting enzyme 2 (ACE2)” NCT06291883 ↗ |
| Modality | Traditional medicine (herbal / TCM) | “novel herbal medicine formula Kang Guan Recipe (KGR)” NCT06291883 ↗ |
| Target | ACE2 | “KGR can block the interaction of viral Spike and human angiotensin-converting enzyme 2 (ACE2)” NCT06291883 ↗ |